Legal News

Court of Appeal—patent for antibodies from mice sufficiently disclosed (Regeneron Pharmaceuticals Inc v Kymab Ltd and another)

Published on: 18 April 2018
Published by: LexisPSL
  • Court of Appeal—patent for antibodies from mice sufficiently disclosed (Regeneron Pharmaceuticals Inc v Kymab Ltd and another)
  • What are the practical implications of the judgment?
  • What was the background?
  • What did the Court of Appeal decide?
  • Summary
  • Sufficiency
  • Infringement and construction
  • Conclusion

Article summary

Intellectual Property analysis: In a case concerning the sufficiency of disclosure of a patent, the Court of Appeal allowed the appeal of the proprietor of two European patents for the production of human antibodies from transgenic mice, which the High Court had revoked on the ground that their specifications did not disclose the invention clearly enough and completely enough for it to be performed by a person skilled in the art. or take a trial to read the full analysis.

Popular documents